article thumbnail

Application of telemedicine technology for cardiovascular diseases management during the COVID-19 pandemic: a scoping review

Frontiers in Cardiovascular Medicine

BackgroundRecently, the use of telemedicine technology has increased due to the Covid-19 pandemic. This study aimed to identify the applications of telemedicine for cardiovascular diseases management during the Covid-19 pandemic.MethodsThis scoping study was conducted in 2023.

article thumbnail

COVID-19 vaccine and postural orthostatic tachycardia syndrome

HeartRhythm

We would like to comment on the publication “Postural orthostatic tachycardia syndrome after COVID-19 vaccination [1].” This study evaluated patients who received the mRNA COVID-19 vaccine and then developed new or worsening symptoms of Postural Orthostatic Tachycardia Syndrome (POTS).

article thumbnail

Prognostic value of ECG monitor findings in COVID-19

Open Heart

Aims COVID-19 can cause severe illness and multiorgan dysfunction. Acute myocardial damage has been detected in a significant portion of patients with COVID-19; therefore, several studies have reported that electrocardiographic findings could be used to evaluate the severalty of COVID-19.

article thumbnail

COVID-19 myocarditis illusions

Dr. Anish Koka

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID. But it got worse.

article thumbnail

Hepatitis B Vaccine Birth Dose Uptake Unimpacted By COVID-19 Pandemic

HCPLive

Refusal of hospital-administered birth doses of the hepatitis B vaccine declined in Washington, DC, from 2017-2022 despite pandemic-related disruptions to other childhood vaccines.

article thumbnail

Abstract 021: Identifying and Dismantling COVID?19 Barriers to Stroke Care

Stroke: Vascular and Interventional Neurology

With decreases in stroke admission across Latin America during COVID19, it is evident that the pandemic has negatively impacted hospitals’ abilities to manage as many stroke cases as before (Pujol‐Lereis et al., 2022; Clement et al., 2005; Soto et al., 2021; Pujol‐Lereis et al.,

article thumbnail

Abstract 112: Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment

Stroke Journal

The COVID-19 pandemic developed midway through VIPS II enrollment, creating an opportunity to assess its impact.Methods:At 22 North American sites, we enrolled 205 children (28 days-18 years) with AIS (12/2016 - 1/2022), collected serum samples up to 7 days post-stroke, and measured clinical infection via parental interview.